Results 61 to 70 of about 6,882 (175)
Cognitive Impairment, Depression and Cerebral Microbleeds in Immune Thrombocytopenia (ITP)
American Journal of Hematology, Volume 101, Issue 11, Page 2934-2938, November 2026.
Camelia Vladescu +10 more
wiley +1 more source
eJHaem, Volume 7, Issue 5, October 2026.ABSTRACT Introduction Although Immune cytopenias such as immune thrombocytopenia (ITP), autoimmune haemolytic anaemia (AIHA) and pure red blood cell aplasia (PRCA) are well documented associations with chronic lymphocytic leukaemia (CLL), aplastic anaemia (AA) is seemingly rare. Case This report describes a case of AA in a CLL patient post commencement
Zachray Wei +3 more
wiley +1 more source
Evaluation of eltrombopag in patients with aplastic anemia in real-world experience
Leukemia Research Reports, 2019 Background: Although eltrombopag has recently been approved for treating AA, the effects of its clinical use remain unknown. Methods: We retrospectively analyzed 11 patients with AA, who had been treated with eltrombopag from August 2017 to May 2018 ...
Akiko Konishi +12 more
doaj +1 more source
The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism [PDF]
HemasphereHemaSphere, Volume 10, Issue 10, October 2026.
Lees C +9 more
europepmc +2 more sources
eJHaem, Volume 7, Issue 5, October 2026.ABSTRACT We present a case of aplastic anemia (AA) complicated with gastric cancer that was successfully treated with cyclosporine A (CsA) and romiplostim (ROMI) as a bridging therapy before curative surgery. This patient had untreated gastric cancer at the time of AA diagnosis, and surgery was difficult because of thrombocytopenia.
Noriharu Nakagawa +2 more
wiley +1 more source
ANZ Journal of Surgery, Volume 96, Issue 10, Page 3116-3125, October 2026.Splenectomy is a safe and effective treatment option in selected patients with haematological disease, despite declining referrals over the last 27 years in the era of targeted therapies. Outcomes are favourable when performed laparoscopically and long‐term follow‐up demonstrates sustained haematologic benefit in surviving patients.
Salil Dutt Barrett +9 more
wiley +1 more source
The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
, 2013 Fazal-i-Akbar Danish,1 Saeeda Yasmin21James Paget University Hospital, Great Yarmouth, Norfolk, United Kingdom; 2Shifa International Hospital, Islamabad, PakistanAbstract: Eltrombopag is a 2nd generation thrombopoietin-receptor agonist. It binds with the
Danish FA, Yasmin S
core
Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
, 2014 BACKGROUND Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver ...
陳培哲 +1 more
core +1 more source
Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach [PDF]
, 2021 Eltrombopag is a thrombopoietin receptor (MPL) agonist approved for the treatment of primary immune thrombocytopenia (ITP). Recent evidence shows that some patients may sustain platelet counts following eltrombopag discontinuation.
Valcárcel, David +7 more
core
British Journal of Haematology, Volume 209, Issue 5, Page 2374-2378, November 2026.
Kayoko Mizuno +6 more
wiley +1 more source